Perpetua Medical AB (publ) (STO:PERP.B)
Sweden · Delayed Price · Currency is SEK 4.820
0.00 (0.00%)
Jan 19, 2026, 12:33 PM CET
Perpetua Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 13.57 | 6.94 | 9.94 | 10.11 | 8.82 | 1.9 | Upgrade | |
Revenue Growth (YoY) | 153.97% | -30.16% | -1.76% | 14.73% | 363.72% | -12.86% | Upgrade |
Cost of Revenue | 6.72 | 3.8 | 4.09 | 3.47 | 2.89 | 0.96 | Upgrade |
Gross Profit | 6.85 | 3.14 | 5.85 | 6.65 | 5.93 | 0.94 | Upgrade |
Selling, General & Admin | 11.32 | 10.94 | 23.78 | 25.56 | 19.37 | 15.73 | Upgrade |
Other Operating Expenses | -10.84 | -5.66 | 0.38 | -0.19 | -0.14 | -0.77 | Upgrade |
Operating Expenses | 1.99 | 5.6 | 24.34 | 25.76 | 19.61 | 15.46 | Upgrade |
Operating Income | 4.86 | -2.46 | -18.49 | -19.11 | -13.68 | -14.51 | Upgrade |
Interest Expense | -0.42 | -0.08 | -0.07 | -0.13 | -0.15 | -0.15 | Upgrade |
Interest & Investment Income | 0.09 | 0.29 | 0.29 | 0.07 | 0.12 | 0.07 | Upgrade |
Earnings From Equity Investments | -0.23 | - | - | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | -0 | - | - | -0 | - | - | Upgrade |
EBT Excluding Unusual Items | 4.3 | -2.24 | -18.28 | -19.16 | -13.71 | -14.59 | Upgrade |
Gain (Loss) on Sale of Assets | 0.04 | 0.04 | - | - | - | - | Upgrade |
Pretax Income | 4.34 | -2.2 | -18.28 | -19.16 | -13.71 | -14.59 | Upgrade |
Income Tax Expense | 0.43 | 0.18 | - | - | - | - | Upgrade |
Earnings From Continuing Operations | 3.91 | -2.38 | -18.28 | -19.16 | -13.71 | -14.59 | Upgrade |
Minority Interest in Earnings | 0.05 | -0.09 | - | - | - | - | Upgrade |
Net Income | 3.96 | -2.47 | -18.28 | -19.16 | -13.71 | -14.59 | Upgrade |
Net Income to Common | 3.96 | -2.47 | -18.28 | -19.16 | -13.71 | -14.59 | Upgrade |
Shares Outstanding (Basic) | 5 | 4 | 2 | 1 | 1 | 0 | Upgrade |
Shares Outstanding (Diluted) | 5 | 4 | 2 | 1 | 1 | 0 | Upgrade |
Shares Change (YoY) | 18.80% | 145.32% | 153.20% | 20.61% | 20.91% | 31.09% | Upgrade |
EPS (Basic) | 0.87 | -0.58 | -10.56 | -28.03 | -24.18 | -31.11 | Upgrade |
EPS (Diluted) | 0.87 | -0.58 | -10.56 | -28.03 | -24.18 | -31.11 | Upgrade |
Free Cash Flow | -4.01 | -7.03 | -16.41 | -19.65 | -15.84 | -13.58 | Upgrade |
Free Cash Flow Per Share | -0.89 | -1.66 | -9.48 | -28.74 | -27.94 | -28.95 | Upgrade |
Gross Margin | 50.50% | 45.27% | 58.85% | 65.72% | 67.26% | 49.68% | Upgrade |
Operating Margin | 35.82% | -35.39% | -186.11% | -188.94% | -155.22% | -763.45% | Upgrade |
Profit Margin | 29.16% | -35.64% | -183.94% | -189.48% | -155.54% | -767.33% | Upgrade |
Free Cash Flow Margin | -29.57% | -101.27% | -165.16% | -194.31% | -179.68% | -714.17% | Upgrade |
EBITDA | 6.37 | -2.13 | -18.31 | -18.72 | -13.3 | -14.01 | Upgrade |
EBITDA Margin | 46.93% | -30.73% | -184.31% | -185.10% | -150.87% | - | Upgrade |
D&A For EBITDA | 1.51 | 0.32 | 0.18 | 0.39 | 0.38 | 0.5 | Upgrade |
EBIT | 4.86 | -2.46 | -18.49 | -19.11 | -13.68 | -14.51 | Upgrade |
EBIT Margin | 35.82% | -35.39% | -186.11% | -188.94% | -155.22% | - | Upgrade |
Revenue as Reported | 25.06 | 14.15 | 9.98 | 10.42 | 9 | 2.77 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.